Form 8-K Tonix Pharmaceuticals For: Mar 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Tech selloff weighs down Wall Street as bond yields climb
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 2c
March 3, 2015 8:26 AM ESTTonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81).
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
... More